The Current Ratio as of December 2025 (TTM) for Neuphoria Therapeutics Inc. (NEUP) is 2.72

According to Neuphoria Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.72. This represents a change of -43.74% compared to the average of 4.84 of the last 4 quarters.

Neuphoria Therapeutics Inc. (NEUP) Historical Current Ratio (quarterly & annually)

How has NEUP Current Ratio performed in the past?

The mean historical Current Ratio of Neuphoria Therapeutics Inc. over the last ten years is 5.20. The current 2.72 Current Ratio has changed 5.14% with respect to the historical average. Over the past ten years (40 quarters), NEUP's Current Ratio was at its highest in in the December 2021 quarter at 13.46. The Current Ratio was at its lowest in in the March 2024 quarter at 0.

Neuphoria Therapeutics Inc. (NEUP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Neuphoria Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neuphoria Therapeutics Inc. (NEUP) Average Current Ratio

How has NEUP Current Ratio performed in the past?

The current Current Ratio of Neuphoria Therapeutics Inc. (NEUP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neuphoria Therapeutics Inc. (NEUP) Current Ratio vs. Peers

How is NEUP’s Current Ratio compared to its peers?

Neuphoria Therapeutics Inc.’s Current Ratio is less than Pheton Holdings Ltd Class A Ordinary Shares (12.40), greater than Inspira Technologies Oxy B.H.N. Ltd. (1.15), less than Biomerica, Inc. (3.48), greater than Profusa, Inc. Common Stock (0.18), less than Aprea Therapeutics, Inc. (5.34), greater than Check-Cap Ltd. (0.15), less than Innovative Eyewear, Inc. (11.98), greater than BioCardia, Inc. (1.62), less than Alzamend Neuro, Inc. (6.03), greater than Lifeward Ltd. (0),

Build a custom stock screener for Neuphoria Therapeutics Inc. (NEUP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuphoria Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neuphoria Therapeutics Inc. (NEUP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neuphoria Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.